9th Annual microRNA: Targets and Tools for Therapeutic Development
04 Mar 2013 - 05 Mar 2013 - Boston Marriott Cambridge, MA, USA
microRNAs are playing an important role in a range of diseases such as cancer, metabolic diseases and cardiovascular disorders. Their involvement in many physiological pathways, makes them an excellent target for pharmaceutical drug development and their use as biomarkers or for profiling and screening turns them into a valuable tool for diagnostics. Join your peers for a program on the latest developments in using miRNA's for health and disease, the novel applications and progress made in manipulating microRNA, and the opportunities for using microRNA as a tool.
The program features a world-class speaker lineup, including representatives from Hoffman-La Roche. Novartis, SomaGenics and Yale School of Medicine. Coverage includes:
• Therapeutic Potential in Inflammation, Cancer and Pain
• New Technological Strategies
• microRNAs as Biomarkers and in Diagnostics
• Tissue-Based Analysis
• Circulating miRNAs
Find the full agenda, speaker list and event updates at http://www.healthtech.com/mrn
Secure your place early to save.